Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| FDA Approves Everolimus for Renal Angiomyolipomas - Medscape |
 |
 |
|
Medscape April 26, 2012 — The US Food and Drug Administration has approved everolimus (Afinitor) for the treatment of renal angiomyolipomas not requiring immediate surgery, in patients with tuberous sclerosis complex. This marks the first drug ever to receive ... Novartis drug Afinitor® approved by FDA as first medication to treat patients ... MarketWatch (press release) Novartis receives FDA approval for Afinitor to treat renal angiomyolipomas |
